Recruiting Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors NCT06667141 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, +13 more Locations HonorHealth Research Institute — Phoenix, Arizona, United States Precision NextGen Oncology & Research Center — Beverly Hills, California, United States Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States Denver Health One — Denver, Colorado, United States View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors NCT01970553 Conditions Neoplasms, Specific Advanced Solid Tumors Locations Hospital Universitario Madrid Sanchinarro — Madrid, Spain Hospital Universitario Virgen del Rocio — Seville, Spain University College of London Hospital — London, United Kingdom View Trial Details
